Background
Methods
TCGA and GSE39582 database
Validation cohort
Ethics statement
Reverse transcription-polymerase chain reaction
Immunohistochemistry (IHC) study
Statistical analysis
Results
MMP19 was an independent prognostic factor for survival in the TCGA cohort
Factor | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) |
P
| HR (95% CI) |
P
| |
Gender | 0.793(0.509–1.234) | 0.303 | NI | |
Age | 1.029(1.010–1.084) |
0.002
| 1.037(1.017–1.056) |
< 0.001
|
T category | 2.680(1.694–4.242) |
< 0.001
| 2.045(1.260–3.320) |
0.004
|
N stage | 1.759(1.371–2.256) |
< 0.001
| 1.573(1.199–2.064) |
0.001
|
M stage | 1.378(1.069–1.778) |
0.013
| 1.092(0.829–1.440) | 0.532 |
Tumor location | 0.777(0.442–1.364) | 0.379 | ||
MMP19 | 1.449(1.108–1.893) |
0.007
| 1.401(1.036–1.894) |
0.028
|
MMP19 was a predictor of recurrence-free survival in the GSE39582 cohort
Factor | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) |
P
| HR (95% CI) |
P
| |
Gender | 0.744(0.528–1.048) | 0.090 | ||
Age | 1.008(0.995–1.021) | 0.233 | ||
T category | 1.916(1.381–2.659) |
< 0.001
| 1.774(1.274–2.468) |
0.001
|
N stage | 1.795(1.451–2.222) |
< 0.001
| 1.669(1.343–2.073) |
< 0.001
|
Tumor location | 1.144(0.810–1.619) | 0.446 | ||
MMP19 | 2.061(1.454–2.921) |
< 0.001
| 1.470(1.025–2.215) |
0.032
|
MMP19 was correlated with inferior clinical characteristics in the validation cohort
Characteristics | Total | MMP19 expression | P value | |
---|---|---|---|---|
Low expression | High expression | |||
Gender | 0.144 | |||
Male | 122 | 56(56.6) | 66(66.7) | |
Female | 76 | 43(43.4) | 33(33.3) | |
Age | 0.190 | |||
≥ 60 | 121 | 65(65.7) | 56(56.6) | |
<60 | 77 | 34(34.3) | 43(43.4) | |
Primary site | 0.776 | |||
colon | 92 | 45(45.5) | 47(47.5) | |
rectum | 106 | 54(54.5) | 52(52.5) | |
Histologic type | 0.756 | |||
Adenocarcinoma | 187 | 94(94.9) | 93(93.9) | |
Mucinous adenocarcinoma | 11 | 5(5.1) | 6(6.1) | |
Histologic grade | 0.177 | |||
Well | 54 | 24(24.2) | 30(30.3) | |
Moderate | 99 | 56(56.6) | 43(43.4) | |
Poor | 45 | 19(19.2) | 26(26.3) | |
T stage | 0.052 | |||
T2 | 17 | 10(10.1) | 7(7.1) | |
T3 | 72 | 43(43.4) | 29(29.3) | |
T4 | 109 | 46(46.5) | 63(63.6) | |
Node status |
0.029
| |||
Negative | 79 | 47(47.5) | 32(32.3) | |
Positive | 119 | 52(52.5) | 67(67.7) | |
Intramural vascular invasion |
0.015
| |||
Negative | 156 | 85(85.9) | 71(71.7) | |
Positive | 42 | 14(14.1) | 28(28.3) | |
Perineural invasion | 0.692 | |||
Negative | 168 | 85(85.9) | 83(83.8) | |
Positive | 30 | 14(14.1) | 16(16.2) | |
CEA status |
0.045
| |||
normal | 137 | 75(75.8) | 62(62.6) | |
high | 61 | 24(24.2) | 37(37.4) |
Increased MMP19 expression indicates a poor prognosis in the validation cohort
Factor | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) |
P
| HR (95% CI) |
P
| |
Gender | 0.924(0.541–1.578) | 0.772 | ||
Age | 1.327(0.790–2.227) | 0.285 | ||
T category | 2.044(1.263–3.307) |
0.004
| 1.527(0.972–2.400) | 0.066 |
N stage | 1.784 (1.285–2.457) |
0.001
| 1.642(1.140–2.365) |
0.008
|
Tumor location | 0.902(0.539–1.509) | 0.694 | ||
Histologic type | 0.900(0.282–2.878) | 0.860 | ||
Grade | 1.200(0.831-1.733) | 0.330 | ||
Intramural vascular invasion | 2.190(1.264–3.796) |
0.005
| 1.337(0.754–2.371) | 0.321 |
Perineural invasion | 1.965(1.076–3.588) |
0.028
| 1.393(0.738–2.628) | 0.306 |
MMP19 | 4.909(2.598–9.275) |
< 0.001
| 4.699(2.461–8.974) |
< 0.001
|
Factor | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) |
P
| HR (95% CI) |
P
| |
Gender | 1.000(0.547–1.827) | 0.999 | ||
Age | 1.416(0.788–2.543) | 0.245 | ||
T category | 2.542(1.396–4.628) |
0.002
| 1.854(1.054–3.260) |
0.032
|
N stage | 1.975 (1.354–2.881) |
< 0.001
| 1.856(1.226–2.810) |
0.003
|
Tumor location | 0.808(0.450–1.450) | 0.475 | ||
Histologic type | 1.206(0.374–3.893) | 0.754 | ||
Grade | 1.155(0.762-1.751) | 0.496 | ||
Intramural vascular invasion | 2.419(1.312–4.458) |
0.005
| 0.927(0.435–1.975) | 0.210 |
Perineural invasion | 1.412(0.680–2.932) | 0.355 | ||
MMP19 | 5.807(2.702–12.483) |
< 0.001
| 5.595(2.573–12.164) |
< 0.001
|